Not recruiting yet
Robotic vs Laparoscopic Gastrectomy for cT4a Gastric Cancer
NCT07331454 · The First Affiliated Hospital with Nanjing Medical University · Updated 12 Jan 2026
- What is being tested
- Robotic Gastrectomy; Laparoscopic Gastrectomy
- For
- Gastric Cancer (GC)
- Kind of study
- Tests a treatment or device on volunteers. Phase 3.
- Who can join
- Ages 18 years to 75 years. About 335 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 Feb 2026, ends 31 Dec 2031. Registered 12 Jan 2026.
- Results
- None posted yet.
In the researchers' words
The goal of this multicenter, randomized, phase III clinical trial is to test whether robot-assisted radical gastrectomy improves 3-year recurrence-free survival versus laparoscopy-assisted radical gastrectomy in adults aged 18-80 years with previously untreated, resectable cT4a gastric adenocarcinoma and non-bulky lymph nodes; the main questions are whether the robotic approach confers superior RFS and maintains equivalent peri-operative safety (Clavien-Dindo ≥ II complications) and better secondary oncologic outcomes, and participants will be randomized 1:1 to undergo standardized D2 resection via robotic or laparoscopic technique and followed for 5 years with scheduled recurrence, survival, and quality-of-life assessments.
Sites
- First Affiliated Hospital with Nanjing Medical UniversityNanjing, Jiangsu, China